Compare DuPont de Nemours Inc (DD) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DuPont de Nemours Inc vs JPMorgan Chase & Co — how do they compare? DuPont de Nemours Inc trades at $134.41 (market cap $17.91B), while JPMorgan Chase & Co trades at $344 (market cap $896.38B). The key difference: JPMorgan Chase & Co is far larger — about 50× DuPont de Nemours Inc's market cap, and DuPont de Nemours Inc pays the higher dividend (1.81%). Which is the better fit depends on your goals.
| DD | JPM | |
|---|---|---|
Market Cap | $17.91B | $896.38B |
Sector | Basic Materials | Financials |
52-Week High | $154.59 | $342.89 |
52-Week Low | $87.72 | $282.84 |
Enterprise Value | $20.37B | — |
Dividend Yield | 1.81% | 1.79% |
Volume | — | 10,479,943 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $132.66, down 1.5% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with strong gross margins (35.01%) but negative net income margin (-0.42%) and ROE (-0.16%). Analyst consensus remains bullish with a $227.20 price target (71% upside), though the company faces legal challenges and persistent net cash outflows. Recent developments include water technology upgrades and a 3:1 reverse stock split effective June 2026.
While analyst optimism and valuation discount to price target suggest potential upside, investors face significant risks including ongoing litigation over 'forever chemicals,' weak profitability trends, and concerning cash flow patterns. The stock's current technical weakness near support levels requires careful monitoring of Q2 2026 earnings results due July 2026.
JPMorgan Chase (JPM) trades at $334.53, down 0.58% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q1 and Q2 2026 earnings beats, with Q1 EPS of $5.94 versus $5.47 expected and Q2 EPS of $7.7 versus $5.59 expected, though Q4 2025 missed expectations. Revenue grew to $181.85B in 2025, with a net income margin of 31.61% and ROE of 17.03%. Analyst consensus is a Moderate Buy with a $369.67 price target, and recent news highlights CEO Jamie Dimon's economic warnings and upcoming bank earnings focus.
JPMorgan's outlook remains positive driven by earnings momentum and solid profitability, but risks include geopolitical tensions, cybersecurity threats from AI, and macroeconomic volatility cited by management. The stock offers potential upside to the consensus target, supported by institutional buying interest, though investors should weigh elevated debt levels and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DuPont de Nemours Inc
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
